Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > MedCap Advisors Names Edward Ahn Managing Director and Chief Science Officer

Abstract:
MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today announced it has appointed Edward Ahn, Ph. D., as Managing Director and Chief Science Officer. Dr. Ahn is a leading expert in the development and commercialization of biomaterials nanotechnology, with over 10 years of industrial and academic experience.

MedCap Advisors Names Edward Ahn Managing Director and Chief Science Officer

Cambridge, MA | Posted on September 8th, 2012

"We are extremely fortunate to have a professional of Edward's caliber join our firm," said Mr. Christopher Velis, CEO of MedCap Advisors. "His expertise is perfectly in tune with our mission to improve health and medical technology, as we stay focused on the intersection at which physicians and patients meet. Ed will be a significant contributor to our team and to our clients."

Dr. Ahn most recently served as Vice President of Biologics Product Development for Pioneerģ Surgical Technology, Inc. and its newly formed biologics division. He successfully developed and launched novel synthetic bone grafts, allograft-based tissue products and structural calcium phosphate nanotechnology in interbody spinal fusion.

In 2001, Dr. Ahn won the Grand Prize in the MIT $50k Business Plan Competition and subsequently used his thesis to found Angstrom Medica, a company focused on commercializing nanotechnology in orthopedics. Here he achieved the first nanomedical device approved by the FDA in 2005; the company was subsequently acquired by Pioneerģ Surgical Technology, Inc.

Dr. Ahn earned his B.S. in Chemical Engineering from Stanford University and M.S. in Chemical Engineering Practice and Ph.D. in Chemical Engineering from MIT. Presently he is a senior lecturer at Harvard University's School of Engineering and Applied Science, and is the Vice-Chairman of the MIT Enterprise Forum of Cambridge. He is also a member of the Scientific Advisory Board of the Center of Innovation for Nanobiotechnology (COIN) and a principal of First Founders, Ltd., a not-for-profit corporation dedicated to building young business ventures emerging from academic and other institutional research.

This announcement also follows on the news of MedCap's move to larger space in Harvard Square in Cambridge.

####

About MedCap Advisors
MedCap Advisors, LLC provides sophisticated strategic business and M&A consulting services exclusively to the medical technology and healthcare sectors. With more than 20 years of expertise in emerging medical devices, biotechnologies, and biologics, the firm's advisers are authorities in the full spectrum of strategic, scientific, and financial strategies that drive the medical marketplace. For more information, please visit www.medcapadvisors.com.

Contacts:
Ebben Zall Group
Michelle Juralewicz
781-449-3244

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Novel 'converter' heralds breakthrough in ultra-fast data processing at nanoscale: Invention bagged four patents and could potentially make microprocessor chips work 1,000 times faster October 20th, 2017

Strange but true: turning a material upside down can sometimes make it softer October 20th, 2017

Leti Coordinating Project to Develop Innovative Drivetrains for 3rd-generation Electric Vehicles: CEA Techís Contribution Includes Litenís Knowhow in Magnetic Materials and Simulation And Letiís Expertise in Wide-bandgap Semiconductors October 20th, 2017

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Caught on camera -- chemical reactions 'filmed' at the single-molecule level March 22nd, 2017

Consulting

Lucintel identifies and prioritizes opportunities for alumina trihydrate (ATH) fillers in the global composites industry August 3rd, 2016

Haydale Wins Major Research Grants September 26th, 2015

Silicon Valley-Based Foresight Valuation Launches STR-IPô, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014

California Nanotechnologies Appoints Dr. Enrique Lavernia to the Board August 6th, 2014

Nanomedicine

Spinning strands hint at folding dynamics: Rice University lab uses magnetic beads to model microscopic proteins, polymers October 17th, 2017

Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting(R) October 10th, 2017

Arrowhead to Present at Chardan Gene Therapy Conference October 3rd, 2017

'CRISPR-Gold' fixes Duchenne muscular dystrophy mutation in mice October 3rd, 2017

Announcements

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Novel 'converter' heralds breakthrough in ultra-fast data processing at nanoscale: Invention bagged four patents and could potentially make microprocessor chips work 1,000 times faster October 20th, 2017

Strange but true: turning a material upside down can sometimes make it softer October 20th, 2017

Leti Coordinating Project to Develop Innovative Drivetrains for 3rd-generation Electric Vehicles: CEA Techís Contribution Includes Litenís Knowhow in Magnetic Materials and Simulation And Letiís Expertise in Wide-bandgap Semiconductors October 20th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project